Table of Content

1 Alirocumab Market Overview
1.1 Product Overview and Scope of Alirocumab
1.2 Alirocumab Segment by Type
1.2.1 Global Alirocumab Market Value Comparison by Type (2024-2034)
1.2.2 Patent
1.2.3 Generic
1.3 Alirocumab Segment by Application
1.3.1 Global Alirocumab Market Value by Application: (2024-2034)
1.3.2 Biochemical Reagents
1.3.3 Pharmaceutical Intermediates
1.4 Global Alirocumab Market Size Estimates and Forecasts
1.4.1 Global Alirocumab Revenue 2018-2034
1.4.2 Global Alirocumab Sales 2018-2034
1.4.3 Global Alirocumab Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Alirocumab Market Competition by Manufacturers
2.1 Global Alirocumab Sales Market Share by Manufacturers (2018-2023)
2.2 Global Alirocumab Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Alirocumab Average Price by Manufacturers (2018-2023)
2.4 Global Alirocumab Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Alirocumab, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alirocumab, Product Type & Application
2.7 Alirocumab Market Competitive Situation and Trends
2.7.1 Alirocumab Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alirocumab Players Market Share by Revenue
2.7.3 Global Alirocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alirocumab Retrospective Market Scenario by Region
3.1 Global Alirocumab Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Alirocumab Global Alirocumab Sales by Region: 2018-2034
3.2.1 Global Alirocumab Sales by Region: 2018-2023
3.2.2 Global Alirocumab Sales by Region: 2024-2034
3.3 Global Alirocumab Global Alirocumab Revenue by Region: 2018-2034
3.3.1 Global Alirocumab Revenue by Region: 2018-2023
3.3.2 Global Alirocumab Revenue by Region: 2024-2034
3.4 North America Alirocumab Market Facts & Figures by Country
3.4.1 North America Alirocumab Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Alirocumab Sales by Country (2018-2034)
3.4.3 North America Alirocumab Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alirocumab Market Facts & Figures by Country
3.5.1 Europe Alirocumab Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Alirocumab Sales by Country (2018-2034)
3.5.3 Europe Alirocumab Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alirocumab Market Facts & Figures by Country
3.6.1 Asia Pacific Alirocumab Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Alirocumab Sales by Country (2018-2034)
3.6.3 Asia Pacific Alirocumab Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alirocumab Market Facts & Figures by Country
3.7.1 Latin America Alirocumab Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Alirocumab Sales by Country (2018-2034)
3.7.3 Latin America Alirocumab Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alirocumab Market Facts & Figures by Country
3.8.1 Middle East and Africa Alirocumab Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Alirocumab Sales by Country (2018-2034)
3.8.3 Middle East and Africa Alirocumab Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alirocumab Sales by Type (2018-2034)
4.1.1 Global Alirocumab Sales by Type (2018-2023)
4.1.2 Global Alirocumab Sales by Type (2024-2034)
4.1.3 Global Alirocumab Sales Market Share by Type (2018-2034)
4.2 Global Alirocumab Revenue by Type (2018-2034)
4.2.1 Global Alirocumab Revenue by Type (2018-2023)
4.2.2 Global Alirocumab Revenue by Type (2024-2034)
4.2.3 Global Alirocumab Revenue Market Share by Type (2018-2034)
4.3 Global Alirocumab Price by Type (2018-2034)
5 Segment by Application
5.1 Global Alirocumab Sales by Application (2018-2034)
5.1.1 Global Alirocumab Sales by Application (2018-2023)
5.1.2 Global Alirocumab Sales by Application (2024-2034)
5.1.3 Global Alirocumab Sales Market Share by Application (2018-2034)
5.2 Global Alirocumab Revenue by Application (2018-2034)
5.2.1 Global Alirocumab Revenue by Application (2018-2023)
5.2.2 Global Alirocumab Revenue by Application (2024-2034)
5.2.3 Global Alirocumab Revenue Market Share by Application (2018-2034)
5.3 Global Alirocumab Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AK Scientific
6.1.1 AK Scientific Corporation Information
6.1.2 AK Scientific Description and Business Overview
6.1.3 AK Scientific Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AK Scientific Alirocumab Product Portfolio
6.1.5 AK Scientific Recent Developments/Updates
6.2 Carbosynth
6.2.1 Carbosynth Corporation Information
6.2.2 Carbosynth Description and Business Overview
6.2.3 Carbosynth Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Carbosynth Alirocumab Product Portfolio
6.2.5 Carbosynth Recent Developments/Updates
6.3 TargetMol Chemicals
6.3.1 TargetMol Chemicals Corporation Information
6.3.2 TargetMol Chemicals Description and Business Overview
6.3.3 TargetMol Chemicals Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TargetMol Chemicals Alirocumab Product Portfolio
6.3.5 TargetMol Chemicals Recent Developments/Updates
6.4 Beijing Aomi Jiade Pharmaceutical Technology
6.4.1 Beijing Aomi Jiade Pharmaceutical Technology Corporation Information
6.4.2 Beijing Aomi Jiade Pharmaceutical Technology Description and Business Overview
6.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Portfolio
6.4.5 Beijing Aomi Jiade Pharmaceutical Technology Recent Developments/Updates
6.5 Hefei Hirisun Pharmatech
6.5.1 Hefei Hirisun Pharmatech Corporation Information
6.5.2 Hefei Hirisun Pharmatech Description and Business Overview
6.5.3 Hefei Hirisun Pharmatech Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hefei Hirisun Pharmatech Alirocumab Product Portfolio
6.5.5 Hefei Hirisun Pharmatech Recent Developments/Updates
6.6 Hubei Widely Chemical Technology
6.6.1 Hubei Widely Chemical Technology Corporation Information
6.6.2 Hubei Widely Chemical Technology Description and Business Overview
6.6.3 Hubei Widely Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hubei Widely Chemical Technology Alirocumab Product Portfolio
6.6.5 Hubei Widely Chemical Technology Recent Developments/Updates
6.7 Hubei Xingcheng Biotechnology
6.6.1 Hubei Xingcheng Biotechnology Corporation Information
6.6.2 Hubei Xingcheng Biotechnology Description and Business Overview
6.6.3 Hubei Xingcheng Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hubei Xingcheng Biotechnology Alirocumab Product Portfolio
6.7.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
6.8 Hubei Zhongshan Medical Technology
6.8.1 Hubei Zhongshan Medical Technology Corporation Information
6.8.2 Hubei Zhongshan Medical Technology Description and Business Overview
6.8.3 Hubei Zhongshan Medical Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hubei Zhongshan Medical Technology Alirocumab Product Portfolio
6.8.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
6.9 Jiangxi Ruiweier Biotechnology
6.9.1 Jiangxi Ruiweier Biotechnology Corporation Information
6.9.2 Jiangxi Ruiweier Biotechnology Description and Business Overview
6.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jiangxi Ruiweier Biotechnology Alirocumab Product Portfolio
6.9.5 Jiangxi Ruiweier Biotechnology Recent Developments/Updates
6.10 Kailide Biomedical Technology
6.10.1 Kailide Biomedical Technology Corporation Information
6.10.2 Kailide Biomedical Technology Description and Business Overview
6.10.3 Kailide Biomedical Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Kailide Biomedical Technology Alirocumab Product Portfolio
6.10.5 Kailide Biomedical Technology Recent Developments/Updates
6.11 Nantong Feiyu Biological Technology
6.11.1 Nantong Feiyu Biological Technology Corporation Information
6.11.2 Nantong Feiyu Biological Technology Alirocumab Description and Business Overview
6.11.3 Nantong Feiyu Biological Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Nantong Feiyu Biological Technology Alirocumab Product Portfolio
6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
6.12 Nantong Hi-Future Biotechnology
6.12.1 Nantong Hi-Future Biotechnology Corporation Information
6.12.2 Nantong Hi-Future Biotechnology Alirocumab Description and Business Overview
6.12.3 Nantong Hi-Future Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Nantong Hi-Future Biotechnology Alirocumab Product Portfolio
6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
6.13 Shanghai Baishikai Chemical Technology
6.13.1 Shanghai Baishikai Chemical Technology Corporation Information
6.13.2 Shanghai Baishikai Chemical Technology Alirocumab Description and Business Overview
6.13.3 Shanghai Baishikai Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Shanghai Baishikai Chemical Technology Alirocumab Product Portfolio
6.13.5 Shanghai Baishikai Chemical Technology Recent Developments/Updates
6.14 Shanghai Biochempartner
6.14.1 Shanghai Biochempartner Corporation Information
6.14.2 Shanghai Biochempartner Alirocumab Description and Business Overview
6.14.3 Shanghai Biochempartner Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Shanghai Biochempartner Alirocumab Product Portfolio
6.14.5 Shanghai Biochempartner Recent Developments/Updates
6.15 Shanghai Loulan Biotechnology
6.15.1 Shanghai Loulan Biotechnology Corporation Information
6.15.2 Shanghai Loulan Biotechnology Alirocumab Description and Business Overview
6.15.3 Shanghai Loulan Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Shanghai Loulan Biotechnology Alirocumab Product Portfolio
6.15.5 Shanghai Loulan Biotechnology Recent Developments/Updates
6.16 Shanghai Macklin Biochemical
6.16.1 Shanghai Macklin Biochemical Corporation Information
6.16.2 Shanghai Macklin Biochemical Alirocumab Description and Business Overview
6.16.3 Shanghai Macklin Biochemical Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Shanghai Macklin Biochemical Alirocumab Product Portfolio
6.16.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.17 Shanghai Minkai Biotechnology
6.17.1 Shanghai Minkai Biotechnology Corporation Information
6.17.2 Shanghai Minkai Biotechnology Alirocumab Description and Business Overview
6.17.3 Shanghai Minkai Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Shanghai Minkai Biotechnology Alirocumab Product Portfolio
6.17.5 Shanghai Minkai Biotechnology Recent Developments/Updates
6.18 Shanghai Ruihui Chemical Technology
6.18.1 Shanghai Ruihui Chemical Technology Corporation Information
6.18.2 Shanghai Ruihui Chemical Technology Alirocumab Description and Business Overview
6.18.3 Shanghai Ruihui Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Shanghai Ruihui Chemical Technology Alirocumab Product Portfolio
6.18.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
6.19 Shanghai Saimai Biotechnology
6.19.1 Shanghai Saimai Biotechnology Corporation Information
6.19.2 Shanghai Saimai Biotechnology Alirocumab Description and Business Overview
6.19.3 Shanghai Saimai Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Shanghai Saimai Biotechnology Alirocumab Product Portfolio
6.19.5 Shanghai Saimai Biotechnology Recent Developments/Updates
6.20 Shanghai Yifei Biotechnology
6.20.1 Shanghai Yifei Biotechnology Corporation Information
6.20.2 Shanghai Yifei Biotechnology Alirocumab Description and Business Overview
6.20.3 Shanghai Yifei Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Shanghai Yifei Biotechnology Alirocumab Product Portfolio
6.20.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.21 Sichuan Weiqi Biotechnology
6.21.1 Sichuan Weiqi Biotechnology Corporation Information
6.21.2 Sichuan Weiqi Biotechnology Alirocumab Description and Business Overview
6.21.3 Sichuan Weiqi Biotechnology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Sichuan Weiqi Biotechnology Alirocumab Product Portfolio
6.21.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
6.22 Taizhou KEDE Chemical
6.22.1 Taizhou KEDE Chemical Corporation Information
6.22.2 Taizhou KEDE Chemical Alirocumab Description and Business Overview
6.22.3 Taizhou KEDE Chemical Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Taizhou KEDE Chemical Alirocumab Product Portfolio
6.22.5 Taizhou KEDE Chemical Recent Developments/Updates
6.23 Taizhou Kerui Bio-Technology
6.23.1 Taizhou Kerui Bio-Technology Corporation Information
6.23.2 Taizhou Kerui Bio-Technology Alirocumab Description and Business Overview
6.23.3 Taizhou Kerui Bio-Technology Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Taizhou Kerui Bio-Technology Alirocumab Product Portfolio
6.23.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
6.24 Tianmen Hengchang Chemical
6.24.1 Tianmen Hengchang Chemical Corporation Information
6.24.2 Tianmen Hengchang Chemical Alirocumab Description and Business Overview
6.24.3 Tianmen Hengchang Chemical Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Tianmen Hengchang Chemical Alirocumab Product Portfolio
6.24.5 Tianmen Hengchang Chemical Recent Developments/Updates
6.25 WeiShi Reagent
6.25.1 WeiShi Reagent Corporation Information
6.25.2 WeiShi Reagent Alirocumab Description and Business Overview
6.25.3 WeiShi Reagent Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.25.4 WeiShi Reagent Alirocumab Product Portfolio
6.25.5 WeiShi Reagent Recent Developments/Updates
6.26 Wuhan Dingxintong Pharmaceutical
6.26.1 Wuhan Dingxintong Pharmaceutical Corporation Information
6.26.2 Wuhan Dingxintong Pharmaceutical Alirocumab Description and Business Overview
6.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Wuhan Dingxintong Pharmaceutical Alirocumab Product Portfolio
6.26.5 Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
6.27 Wuhan Fortuna Chemical
6.27.1 Wuhan Fortuna Chemical Corporation Information
6.27.2 Wuhan Fortuna Chemical Alirocumab Description and Business Overview
6.27.3 Wuhan Fortuna Chemical Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Wuhan Fortuna Chemical Alirocumab Product Portfolio
6.27.5 Wuhan Fortuna Chemical Recent Developments/Updates
6.28 Wuhan Sunrise Technology Development
6.28.1 Wuhan Sunrise Technology Development Corporation Information
6.28.2 Wuhan Sunrise Technology Development Alirocumab Description and Business Overview
6.28.3 Wuhan Sunrise Technology Development Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.28.4 Wuhan Sunrise Technology Development Alirocumab Product Portfolio
6.28.5 Wuhan Sunrise Technology Development Recent Developments/Updates
6.29 Wuhan Weisman Bioengineering
6.29.1 Wuhan Weisman Bioengineering Corporation Information
6.29.2 Wuhan Weisman Bioengineering Alirocumab Description and Business Overview
6.29.3 Wuhan Weisman Bioengineering Alirocumab Sales, Revenue and Gross Margin (2018-2023)
6.29.4 Wuhan Weisman Bioengineering Alirocumab Product Portfolio
6.29.5 Wuhan Weisman Bioengineering Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alirocumab Industry Chain Analysis
7.2 Alirocumab Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alirocumab Production Mode & Process
7.4 Alirocumab Sales and Marketing
7.4.1 Alirocumab Sales Channels
7.4.2 Alirocumab Distributors
7.5 Alirocumab Customers
8 Alirocumab Market Dynamics
8.1 Alirocumab Industry Trends
8.2 Alirocumab Market Drivers
8.3 Alirocumab Market Challenges
8.4 Alirocumab Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Alirocumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Alirocumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Alirocumab Market Competitive Situation by Manufacturers in 2024
Table 4. Global Alirocumab Sales (Kg) of Key Manufacturers (2018-2023)
Table 5. Global Alirocumab Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Alirocumab Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Alirocumab Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Alirocumab Average Price (US$/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Alirocumab, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Alirocumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alirocumab, Product Type & Application
Table 12. Global Key Manufacturers of Alirocumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alirocumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alirocumab as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alirocumab Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Alirocumab Sales by Region (2018-2023) & (Kg)
Table 18. Global Alirocumab Sales Market Share by Region (2018-2023)
Table 19. Global Alirocumab Sales by Region (2024-2034) & (Kg)
Table 20. Global Alirocumab Sales Market Share by Region (2024-2034)
Table 21. Global Alirocumab Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Alirocumab Revenue Market Share by Region (2018-2023)
Table 23. Global Alirocumab Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Alirocumab Revenue Market Share by Region (2024-2034)
Table 25. North America Alirocumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Alirocumab Sales by Country (2018-2023) & (Kg)
Table 27. North America Alirocumab Sales by Country (2024-2034) & (Kg)
Table 28. North America Alirocumab Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Alirocumab Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Alirocumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Alirocumab Sales by Country (2018-2023) & (Kg)
Table 32. Europe Alirocumab Sales by Country (2024-2034) & (Kg)
Table 33. Europe Alirocumab Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Alirocumab Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Alirocumab Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Alirocumab Sales by Region (2018-2023) & (Kg)
Table 37. Asia Pacific Alirocumab Sales by Region (2024-2034) & (Kg)
Table 38. Asia Pacific Alirocumab Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Alirocumab Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Alirocumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Alirocumab Sales by Country (2018-2023) & (Kg)
Table 42. Latin America Alirocumab Sales by Country (2024-2034) & (Kg)
Table 43. Latin America Alirocumab Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Alirocumab Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Alirocumab Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Alirocumab Sales by Country (2018-2023) & (Kg)
Table 47. Middle East & Africa Alirocumab Sales by Country (2024-2034) & (Kg)
Table 48. Middle East & Africa Alirocumab Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Alirocumab Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Alirocumab Sales (Kg) by Type (2018-2023)
Table 51. Global Alirocumab Sales (Kg) by Type (2024-2034)
Table 52. Global Alirocumab Sales Market Share by Type (2018-2023)
Table 53. Global Alirocumab Sales Market Share by Type (2024-2034)
Table 54. Global Alirocumab Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Alirocumab Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Alirocumab Revenue Market Share by Type (2018-2023)
Table 57. Global Alirocumab Revenue Market Share by Type (2024-2034)
Table 58. Global Alirocumab Price (US$/Kg) by Type (2018-2023)
Table 59. Global Alirocumab Price (US$/Kg) by Type (2024-2034)
Table 60. Global Alirocumab Sales (Kg) by Application (2018-2023)
Table 61. Global Alirocumab Sales (Kg) by Application (2024-2034)
Table 62. Global Alirocumab Sales Market Share by Application (2018-2023)
Table 63. Global Alirocumab Sales Market Share by Application (2024-2034)
Table 64. Global Alirocumab Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Alirocumab Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Alirocumab Revenue Market Share by Application (2018-2023)
Table 67. Global Alirocumab Revenue Market Share by Application (2024-2034)
Table 68. Global Alirocumab Price (US$/Kg) by Application (2018-2023)
Table 69. Global Alirocumab Price (US$/Kg) by Application (2024-2034)
Table 70. AK Scientific Corporation Information
Table 71. AK Scientific Description and Business Overview
Table 72. AK Scientific Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 73. AK Scientific Alirocumab Product
Table 74. AK Scientific Recent Developments/Updates
Table 75. Carbosynth Corporation Information
Table 76. Carbosynth Description and Business Overview
Table 77. Carbosynth Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 78. Carbosynth Alirocumab Product
Table 79. Carbosynth Recent Developments/Updates
Table 80. TargetMol Chemicals Corporation Information
Table 81. TargetMol Chemicals Description and Business Overview
Table 82. TargetMol Chemicals Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 83. TargetMol Chemicals Alirocumab Product
Table 84. TargetMol Chemicals Recent Developments/Updates
Table 85. Beijing Aomi Jiade Pharmaceutical Technology Corporation Information
Table 86. Beijing Aomi Jiade Pharmaceutical Technology Description and Business Overview
Table 87. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 88. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product
Table 89. Beijing Aomi Jiade Pharmaceutical Technology Recent Developments/Updates
Table 90. Hefei Hirisun Pharmatech Corporation Information
Table 91. Hefei Hirisun Pharmatech Description and Business Overview
Table 92. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 93. Hefei Hirisun Pharmatech Alirocumab Product
Table 94. Hefei Hirisun Pharmatech Recent Developments/Updates
Table 95. Hubei Widely Chemical Technology Corporation Information
Table 96. Hubei Widely Chemical Technology Description and Business Overview
Table 97. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 98. Hubei Widely Chemical Technology Alirocumab Product
Table 99. Hubei Widely Chemical Technology Recent Developments/Updates
Table 100. Hubei Xingcheng Biotechnology Corporation Information
Table 101. Hubei Xingcheng Biotechnology Description and Business Overview
Table 102. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 103. Hubei Xingcheng Biotechnology Alirocumab Product
Table 104. Hubei Xingcheng Biotechnology Recent Developments/Updates
Table 105. Hubei Zhongshan Medical Technology Corporation Information
Table 106. Hubei Zhongshan Medical Technology Description and Business Overview
Table 107. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 108. Hubei Zhongshan Medical Technology Alirocumab Product
Table 109. Hubei Zhongshan Medical Technology Recent Developments/Updates
Table 110. Jiangxi Ruiweier Biotechnology Corporation Information
Table 111. Jiangxi Ruiweier Biotechnology Description and Business Overview
Table 112. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 113. Jiangxi Ruiweier Biotechnology Alirocumab Product
Table 114. Jiangxi Ruiweier Biotechnology Recent Developments/Updates
Table 115. Kailide Biomedical Technology Corporation Information
Table 116. Kailide Biomedical Technology Description and Business Overview
Table 117. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 118. Kailide Biomedical Technology Alirocumab Product
Table 119. Kailide Biomedical Technology Recent Developments/Updates
Table 120. Nantong Feiyu Biological Technology Corporation Information
Table 121. Nantong Feiyu Biological Technology Description and Business Overview
Table 122. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 123. Nantong Feiyu Biological Technology Alirocumab Product
Table 124. Nantong Feiyu Biological Technology Recent Developments/Updates
Table 125. Nantong Hi-Future Biotechnology Corporation Information
Table 126. Nantong Hi-Future Biotechnology Description and Business Overview
Table 127. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 128. Nantong Hi-Future Biotechnology Alirocumab Product
Table 129. Nantong Hi-Future Biotechnology Recent Developments/Updates
Table 130. Shanghai Baishikai Chemical Technology Corporation Information
Table 131. Shanghai Baishikai Chemical Technology Description and Business Overview
Table 132. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 133. Shanghai Baishikai Chemical Technology Alirocumab Product
Table 134. Shanghai Baishikai Chemical Technology Recent Developments/Updates
Table 135. Shanghai Biochempartner Corporation Information
Table 136. Shanghai Biochempartner Description and Business Overview
Table 137. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 138. Shanghai Biochempartner Alirocumab Product
Table 139. Shanghai Biochempartner Recent Developments/Updates
Table 140. Shanghai Loulan Biotechnology Corporation Information
Table 141. Shanghai Loulan Biotechnology Description and Business Overview
Table 142. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 143. Shanghai Loulan Biotechnology Alirocumab Product
Table 144. Shanghai Loulan Biotechnology Recent Developments/Updates
Table 145. Shanghai Macklin Biochemical Corporation Information
Table 146. Shanghai Macklin Biochemical Description and Business Overview
Table 147. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 148. Shanghai Macklin Biochemical Alirocumab Product
Table 149. Shanghai Macklin Biochemical Recent Developments/Updates
Table 150. Shanghai Minkai Biotechnology Corporation Information
Table 151. Shanghai Minkai Biotechnology Description and Business Overview
Table 152. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 153. Shanghai Minkai Biotechnology Alirocumab Product
Table 154. Shanghai Minkai Biotechnology Recent Developments/Updates
Table 155. Shanghai Ruihui Chemical Technology Corporation Information
Table 156. Shanghai Ruihui Chemical Technology Description and Business Overview
Table 157. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 158. Shanghai Ruihui Chemical Technology Alirocumab Product
Table 159. Shanghai Ruihui Chemical Technology Recent Developments/Updates
Table 160. Shanghai Saimai Biotechnology Corporation Information
Table 161. Shanghai Saimai Biotechnology Description and Business Overview
Table 162. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 163. Shanghai Saimai Biotechnology Alirocumab Product
Table 164. Shanghai Saimai Biotechnology Recent Developments/Updates
Table 165. Shanghai Yifei Biotechnology Corporation Information
Table 166. Shanghai Yifei Biotechnology Description and Business Overview
Table 167. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 168. Shanghai Yifei Biotechnology Alirocumab Product
Table 169. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 170. Sichuan Weiqi Biotechnology Corporation Information
Table 171. Sichuan Weiqi Biotechnology Description and Business Overview
Table 172. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 173. Sichuan Weiqi Biotechnology Alirocumab Product
Table 174. Sichuan Weiqi Biotechnology Recent Developments/Updates
Table 175. Taizhou KEDE Chemical Corporation Information
Table 176. Taizhou KEDE Chemical Description and Business Overview
Table 177. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 178. Taizhou KEDE Chemical Alirocumab Product
Table 179. Taizhou KEDE Chemical Recent Developments/Updates
Table 180. Taizhou Kerui Bio-Technology Corporation Information
Table 181. Taizhou Kerui Bio-Technology Description and Business Overview
Table 182. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 183. Taizhou Kerui Bio-Technology Alirocumab Product
Table 184. Taizhou Kerui Bio-Technology Recent Developments/Updates
Table 185. Tianmen Hengchang Chemical Corporation Information
Table 186. Tianmen Hengchang Chemical Description and Business Overview
Table 187. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 188. Tianmen Hengchang Chemical Alirocumab Product
Table 189. Tianmen Hengchang Chemical Recent Developments/Updates
Table 190. WeiShi Reagent Corporation Information
Table 191. WeiShi Reagent Description and Business Overview
Table 192. WeiShi Reagent Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 193. WeiShi Reagent Alirocumab Product
Table 194. WeiShi Reagent Recent Developments/Updates
Table 195. Wuhan Dingxintong Pharmaceutical Corporation Information
Table 196. Wuhan Dingxintong Pharmaceutical Description and Business Overview
Table 197. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 198. Wuhan Dingxintong Pharmaceutical Alirocumab Product
Table 199. Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
Table 200. Wuhan Fortuna Chemical Corporation Information
Table 201. Wuhan Fortuna Chemical Description and Business Overview
Table 202. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 203. Wuhan Fortuna Chemical Alirocumab Product
Table 204. Wuhan Fortuna Chemical Recent Developments/Updates
Table 205. Wuhan Sunrise Technology Development Corporation Information
Table 206. Wuhan Sunrise Technology Development Description and Business Overview
Table 207. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 208. Wuhan Sunrise Technology Development Alirocumab Product
Table 209. Wuhan Sunrise Technology Development Recent Developments/Updates
Table 210. Wuhan Weisman Bioengineering Corporation Information
Table 211. Wuhan Weisman Bioengineering Description and Business Overview
Table 212. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 213. Wuhan Weisman Bioengineering Alirocumab Product
Table 214. Wuhan Weisman Bioengineering Recent Developments/Updates
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Alirocumab Distributors List
Table 218. Alirocumab Customers List
Table 219. Alirocumab Market Trends
Table 220. Alirocumab Market Drivers
Table 221. Alirocumab Market Challenges
Table 222. Alirocumab Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alirocumab
Figure 2. Global Alirocumab Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Alirocumab Market Share by Type in 2024 & 2034
Figure 4. Patent Product Picture
Figure 5. Generic Product Picture
Figure 6. Global Alirocumab Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Alirocumab Market Share by Application in 2024 & 2034
Figure 8. Biochemical Reagents
Figure 9. Pharmaceutical Intermediates
Figure 10. Global Alirocumab Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Alirocumab Market Size (2018-2034) & (US$ Million)
Figure 12. Global Alirocumab Sales (2018-2034) & (Kg)
Figure 13. Global Alirocumab Average Price (US$/Kg) & (2018-2034)
Figure 14. Alirocumab Report Years Considered
Figure 15. Alirocumab Sales Share by Manufacturers in 2024
Figure 16. Global Alirocumab Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Alirocumab Players: Market Share by Revenue in 2024
Figure 18. Alirocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Alirocumab Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Alirocumab Sales Market Share by Country (2018-2034)
Figure 21. North America Alirocumab Revenue Market Share by Country (2018-2034)
Figure 22. United States Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Alirocumab Sales Market Share by Country (2018-2034)
Figure 25. Europe Alirocumab Revenue Market Share by Country (2018-2034)
Figure 26. Germany Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Alirocumab Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Alirocumab Revenue Market Share by Region (2018-2034)
Figure 33. China Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. China Taiwan Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Latin America Alirocumab Sales Market Share by Country (2018-2034)
Figure 43. Latin America Alirocumab Revenue Market Share by Country (2018-2034)
Figure 44. Mexico Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Brazil Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Argentina Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Alirocumab Sales Market Share by Country (2018-2034)
Figure 48. Middle East & Africa Alirocumab Revenue Market Share by Country (2018-2034)
Figure 49. Turkey Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. UAE Alirocumab Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Alirocumab by Type (2018-2034)
Figure 53. Global Revenue Market Share of Alirocumab by Type (2018-2034)
Figure 54. Global Alirocumab Price (US$/Kg) by Type (2018-2034)
Figure 55. Global Sales Market Share of Alirocumab by Application (2018-2034)
Figure 56. Global Revenue Market Share of Alirocumab by Application (2018-2034)
Figure 57. Global Alirocumab Price (US$/Kg) by Application (2018-2034)
Figure 58. Alirocumab Value Chain
Figure 59. Alirocumab Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed